ETFs with CMG Pharmaceutical Co., Ltd. (058820) Exposure
The following ETFs maintain exposure to CMG Pharmaceutical Co., Ltd. (KR:058820). ETF holdings data are updated periodically, based on the latest holdings the ETFs report, and are subject to change. To see a complete breakdown of any of the ETFs included in the table below, including asset class, AUM, and country allocations, click on the ticker symbol.
11 ETFs Hold CMG Pharmaceutical Co., Ltd. (058820)
| Symbol | ETF Name | AUM | Expense Ratio | % Weight in ETF | Market Value | % Weight in 058820 |
|---|---|---|---|---|---|---|
| VA | Vanguard Dev AsiaPac | $363.21M | 0.22% | <0.01% | $3,159.19 | 0.01% |
| VIU | Vanguard exNA Idx Un | $11.53B | 0.23% | <0.01% | $118.48K | 1.11% |
| VSS | Vanguard FTSE All-World ex-US Small-Cap ETF | $11.21B | 0.06% | <0.01% | $33.66K | 0.55% |
| VPL | Vanguard FTSE Pacific ETF | $8.65B | 0.07% | <0.01% | $29.37K | 0.48% |
| DFEM | Dimensional Emerging Markets Core Equity 2 ETF | $9.08B | 0.39% | <0.01% | $12.27K | 0.03% |
| DFAX | Dimensional World ex U.S. Core Equity 2 ETF | $12.19B | 0.28% | <0.01% | $11.18K | 0.02% |
| VEA | Vanguard FTSE Developed Markets ETF | $231.73B | 0.03% | <0.01% | $251.98K | 4.11% |
| DFAE | Dimensional Emerging Core Equity Market ETF | $9.42B | 0.29% | <0.01% | $5,457.19 | 0.01% |
| VXUS | Vanguard Total International Stock ETF | $163.15B | 0.05% | <0.01% | $365.66K | 5.96% |
| DEXC | Dimensional Emerging Markets ex China Core Equity ETF | $276.59M | 0.43% | <0.01% | $55.59 | <0.01% |
| VT | Vanguard Total World Stock ETF | $84.28B | 0.06% | <0.01% | $11.36K | 0.19% |
| Symbol | % Weight in ETF | ETF Name | AUM | Expense Ratio | Market Value | % Weight in 058820 |
|---|---|---|---|---|---|---|
| VA | <0.01% | Vanguard Dev AsiaPac | $363.21M | 0.22% | $3,159.19 | 0.01% |
| VIU | <0.01% | Vanguard exNA Idx Un | $11.53B | 0.23% | $118.48K | 1.11% |
| VSS | <0.01% | Vanguard FTSE All-World ex-US Small-Cap ETF | $11.21B | 0.06% | $33.66K | 0.55% |
| VPL | <0.01% | Vanguard FTSE Pacific ETF | $8.65B | 0.07% | $29.37K | 0.48% |
| DFEM | <0.01% | Dimensional Emerging Markets Core Equity 2 ETF | $9.08B | 0.39% | $12.27K | 0.03% |
| DFAX | <0.01% | Dimensional World ex U.S. Core Equity 2 ETF | $12.19B | 0.28% | $11.18K | 0.02% |
| VEA | <0.01% | Vanguard FTSE Developed Markets ETF | $231.73B | 0.03% | $251.98K | 4.11% |
| DFAE | <0.01% | Dimensional Emerging Core Equity Market ETF | $9.42B | 0.29% | $5,457.19 | 0.01% |
| VXUS | <0.01% | Vanguard Total International Stock ETF | $163.15B | 0.05% | $365.66K | 5.96% |
| DEXC | <0.01% | Dimensional Emerging Markets ex China Core Equity ETF | $276.59M | 0.43% | $55.59 | <0.01% |
| VT | <0.01% | Vanguard Total World Stock ETF | $84.28B | 0.06% | $11.36K | 0.19% |
Popular ETF Comparisons
058820 ETF Exposure FAQ
What ETFs hold CMG Pharmaceutical Co., Ltd. stock?
CMG Pharmaceutical Co., Ltd. (KR:058820) is currently held by 11 ETFs in TipRanks’ ETF exposure database. The ETF(s) with exposure to KR:058820 include Vanguard (VXUS), Vanguard (VEA) and Vanguard (TSE:VIU).
Which ETF has the largest exposure to KR:058820?
The ETF with the largest exposure to KR:058820 is Vanguard (VXUS), with approximately KRW 365.66K in market value exposure.
How much KR:058820 stock is held by ETFs?
ETFs currently hold approximately KRW 831.28K worth of CMG Pharmaceutical Co., Ltd. (KR:058820) stock, based on TipRanks’ ETF exposure data.
How often is ETF exposure data updated?
ETF exposure data is updated periodically based on the latest available ETF holdings and reporting data. Actual ETF positions may change between reporting periods.
